Skip to main navigation Skip to search Skip to main content

Circulating Sex Hormones and Risk of Colorectal Adenomas and Serrated Lesions in Men

  • Jane C. Figueiredo
  • , Gillian Gresham
  • , Elizabeth L. Barry
  • , Leila A. Mott
  • , Michael N. Passarelli
  • , Patrick T. Bradshaw
  • , Carlton W. Anderson
  • , John A. Baron
  • Cedars-Sinai Medical Center
  • Dartmouth College
  • University of California at Berkeley
  • University of North Carolina at Chapel Hill

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Background: Sex hormones have been implicated in the etiology of colorectal neoplasia in women for over 40 years, but there has been very little investigation of the role of these hormones in men. Methods: Using data from an adenoma chemoprevention trial, we conducted a secondary analysis to examine serum hormone levels [testosterone, androstenedione, DHEA sulfate (DHEAS), and sex hormone binding globulin (SHBG)] and risk of colorectal precursors in 925 men. Multivariable logistic regression models were fit to evaluate adjusted associations between hormone levels and risk of "low-risk" (single tubular adenoma < 1 cm) and "highrisk" lesions (advanced adenoma or sessile serrated adenoma or right-sided serrated polyp or <2 adenomas of any size). Results: Overall, levels of free testosterone, total testosterone, androstenedione, DHEAS, or SHBG were not associated with either "low-risk" or "high-risk" early precursor lesions in the colorectum. Conclusions: These findings do not support the role of sex hormones in early colorectal neoplasia among men.

Original languageEnglish
Pages (from-to)293-295
Number of pages3
JournalCancer Epidemiology Biomarkers and Prevention
Volume31
Issue number1
DOIs
StatePublished - Jan 2022

Fingerprint

Dive into the research topics of 'Circulating Sex Hormones and Risk of Colorectal Adenomas and Serrated Lesions in Men'. Together they form a unique fingerprint.

Cite this